Aug 3 (Reuters)-
SymBio Pharmaceuticals Limited
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2017 Jun 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.79 1.21 2.90
(+47.5 pct) (+24.0 pct) (+22.6 pct)
Operating loss 1.24 loss 819 mln loss 3.24
Recurring loss 1.27 loss 1.18 loss 3.30
Net loss 1.27 loss 1.18 loss 3.31
EPS loss 26.09 yen loss 33.93 yen loss 71.07 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T
((Tokyo Headline News Desk +813 6441 1812))